Eagle Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-1,936,365
Closed -$19.3M 691
2015
Q2
$19.3M Buy
1,936,365
+555,768
+40% +$5.55M 0.11% 231
2015
Q1
$17.6M Sell
1,380,597
-810,864
-37% -$10.3M 0.1% 246
2014
Q4
$31M Buy
2,191,461
+142,733
+7% +$2.02M 0.18% 176
2014
Q3
$28.2M Buy
2,048,728
+486,458
+31% +$6.69M 0.16% 182
2014
Q2
$24M Buy
1,562,270
+214,929
+16% +$3.31M 0.13% 208
2014
Q1
$23M Buy
+1,347,341
New +$23M 0.13% 227